rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jonathan Jian Wang

Director

Company insider

Files Form 4 as: Director, ImageneBio; Director and 10% owner, Response Biomedical.

Every Form 4 they filed

In numbers

Trades disclosed
31
Buys
1
Sells
0
Bought
$500K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
15 Aug 2012
Last trade
16 Jun 2026
Last filed
18 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IMA ImageneBioDirector · Biotechnology · last 16 Jun 20260 buys · 0 sells
Response BiomedicalDirector, 10% owner · last 29 Nov 20161 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 18 Jun 2026IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—15,600 at $0.00filing
16 Jun 2026filed 18 Jun 2026IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—15,600 at $0.00filing
18 Dec 2025filed 22 Dec 2025IMA ImageneBiooption or derivative · BiotechnologySEC FORM 4 Code A—31,200 at $0.00filing
25 Jul 2025filed 15 Aug 2025IMA ImageneBioBiotechnologySEC FORM 4 Code A—143,832filing
25 Jul 2025filed 15 Aug 2025IMA ImageneBioBiotechnologySEC FORM 4 Code A—971,173filing
29 Nov 2016filed 1 Dec 2016Response BiomedicalSEC FORM 4 Code J—71,396filing
29 Nov 2016filed 1 Dec 2016Response BiomedicalSEC FORM 4 Code J—3,604,266filing
29 Nov 2016filed 1 Dec 2016Response BiomedicalSEC FORM 4 Code J—34,291filing
29 Nov 2016filed 1 Dec 2016Response BiomedicalSEC FORM 4 Code J—2,149,902filing
29 Nov 2016filed 1 Dec 2016Response Biomedicaloption or derivativeSEC FORM 4 Code D—20,000filing
29 Nov 2016filed 1 Dec 2016Response Biomedicaloption or derivativeSEC FORM 4 Code D—5,000filing
29 Nov 2016filed 1 Dec 2016Response Biomedicaloption or derivativeSEC FORM 4 Code D—5,000filing
29 Nov 2016filed 1 Dec 2016Response Biomedicaloption or derivativeSEC FORM 4 Code D—5,000filing
29 Nov 2016filed 1 Dec 2016Response Biomedicaloption or derivativeSEC FORM 4 Code D—20,000filing
16 Jun 2016filed 20 Jun 2016Response BiomedicalSEC FORM 4 Bought$312K556,339 at $0.56filing
16 Jun 2016filed 20 Jun 2016Response BiomedicalSEC FORM 4 Bought$2,9655,294 at $0.56filing
16 Jun 2016filed 20 Jun 2016Response BiomedicalSEC FORM 4 Bought$185K331,225 at $0.56filing
24 Mar 2016filed 28 Mar 2016Response BiomedicalSEC FORM 4 Code A—26,176 at $0.00filing
24 Mar 2016filed 28 Mar 2016Response Biomedicaloption or derivativeSEC FORM 4 Code A—5,000 at $0.00filing
19 May 2015filed 21 May 2015Response BiomedicalSEC FORM 4 Code A—7,291 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Yanina Grant-HuertaChief Financial Officer · Chief Financial Officer at ImageneBio, filing Form 4 there in the last year
Kristin YaremaChief Executive Officer · Chief Executive Officer at ImageneBio, filing Form 4 there in the last year
Robert B. LallyPrincipal Accounting Officer · Principal Accounting Officer at ImageneBio, filing Form 4 there in the last year
Otello StampacchiaDirector · Director at ImageneBio, filing Form 4 there in the last year
David P. BonitaDirector · Director at ImageneBio, filing Form 4 there in the last year